Clinical Trial Update: Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial update for perampanel as adjunctive therapy in pediatric partial onset seizures or primary generalized tonic-clonic seizures; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Tonic-clonic Seizures
• Partial-onset Seizures

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Partial-Onset or Primary Generalized Tonic-Clonic Seizures | Phase 3 | Status: COMPLETED | Results posted: 2020-04-06